Sentence examples for prospective therapy from inspiring English sources
I.N.D.s are intended to capture every aspect of a prospective therapy in exacting detail.
This study revealed that daptomycin nanocarrier system could be used in future to deliver this antibiotic directly into the eye, in order to act as a prospective therapy against bacterial endophthalmitis and as an efficient alternative to chitosan nanoparticles [86].
Wilson [ 5] emphasized that informing patients adequately causes increased compliance and reduced anxiety towards prospective therapy, emphasizing the need to assess these patient-related factors [ 5- 11].
It is because few prospective trials for gliomas have attempted to select prospective therapy on the basis of in vitro analyses.
In addition to those prognostic factors being already indicative for adjuvant therapy like lymph nodes and grading, a randomized prospective therapy intervention study based on the decrease of CEA would be needed to prove the relevance of our findings.
Although few anti-microtubule cancer drugs have produced a positive effect on EHCC in current clinical practice, the combination of taxane and anti-STMN1 drugs may provide a prospective therapy against various cancers in the future.
While a number of available and prospective therapies target hepatic dysregulation either directly or indirectly, including metformin, glucagon-like peptide-1 (GLP-1) analogs, glucagon receptor antagonists, thiazolidinediones, and enzyme inhibitors of gluconeogenesis [25], the use of inhibitors of GSL synthesis is mechanistically quite distinct from these approaches.
Further characterization of the stem cell population is required to identify potential targets for prospective therapies [ 26, 27].
In this scenario, the identification of causative, targetable biomarkers for the basal subtype, which could be challenged for prospective therapies, remains an unmet clinical need.
Building on these successes it may also be possible to envisage in the future, the use of such methods to predict aggregation propensity in vivo, of immense potential importance for the design of prospective therapies.
We would also argue that prospective therapies should not focus on reducing the content of cardiac TAGs but rather prioritize the burden of derived molecules with greater toxicity such as diacylglycerides and ceramides.
